Ulrike Söling

First-line therapy with fludarabine compared with chlorambucil does not result in a major benefit for elderly patients with advanced chronic lymphocytic leukemia

Barbara Eichhorst, Raymonde Busch, Stephan Stilgenbauer et al. · Blood · 2009 · 333 citations

Subcutaneous Alemtuzumab in Fludarabine-Refractory Chronic Lymphocytic Leukemia: Clinical Results and Prognostic Marker Analyses From the CLL2H Study of the German Chronic Lymphocytic Leukemia Study Group

Stephan Stilgenbauer, Thorsten Zenz, Dirk Winkler et al. · Journal of Clinical Oncology · 2009 · 270 citations · Full text

Significantly longer time to deterioration of quality of life due to CANKADO PRO-React eHealth support in HR+ HER2− metastatic breast cancer patients receiving palbociclib and endocrine therapy: primary outcome analysis of the multicenter randomized AGO-B WSG PreCycle trial

Nadia Harbeck, Peter A. Fasching, Rachel Wuerstlein et al. · Annals of Oncology · 2023 · 39 citations · Full text

A prospective observational study of anaemia management in cancer patients - results from the German Cancer Anaemia Registry

T. Steinmetz, Uwe Totzke, Michael Schweigert et al. · European Journal of Cancer Care · 2010 · 23 citations

Final Effectiveness and Safety Results of NABUCCO: Real-World Data From a Noninterventional, Prospective, Multicenter Study in 697 Patients With Metastatic Breast Cancer Treated With nab-Paclitaxel

Norbert Marschner, Christoph Salat, Ulrike Söling et al. · Clinical Breast Cancer · 2018 · 16 citations · Full text